Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate

Media release Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate Zurich / Vilnius, Jan 2021 Venture Valuation/Biotechgate announce a cooperation with Enterprise Lithuania, trade promotion governmental agency. As per the agreement of the two parties, the Lithuanian Biotech Database has been set-up, a regional portal integrated with Biotechgate Business Development Database. Access to the portal … Continue reading Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate

Read more

Winning start-ups as customers – timing is crucial

Working with start-ups can be both highly promising and risky. On the one hand, there is no greater potential for the future as with an emerging company. On the other hand, new entrepreneurs often lack the funds to be able to make a long-term commitment with partners and suppliers. That is why the right timing … Continue reading Winning start-ups as customers – timing is crucial

Read more

Life science asset database

We regularly hear about new licensing agreements between pharmaceutical and biotech companies. These usually involve assets – such as therapeutics, diagnostics, medical devices or technologies – which are to be developed or marketed together. A big challenge however is to find the right partner for the right asset. The Biotechgate database features almost 90,000 life … Continue reading Life science asset database

Read more

Launch of the Life Science Directory for Medicen Paris

Media Release Launch of the Life Science Directory for Medicen Paris Zurich / Paris, Oct 2020 – Venture Valuation owned Biotechgate announces the partnership with Medicen Paris Region to create a directory of Life Sciences companies. The online directory makes it easier to find partners in one of the key clusters in Europe. Venture Valuation/Biotechgate … Continue reading Launch of the Life Science Directory for Medicen Paris

Read more

Canadian Life Science Market Trend Analysis 2020

Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.

Read more

Denmark Life Science Market Trend Analysis 2020

The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the … Continue reading Denmark Life Science Market Trend Analysis 2020

Read more

Swiss Life Science Market Trend Analysis 2020

Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.

Read more